| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |